The next generation biopharmaceuticals

Affibody is a Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.

Affibodys latest Press releases

To the archive

2019-11-15

Interim Report – January to September 2019

Affibody Medical AB (publ) (“Affibody” or “the Company”), a Swedish biotechcompany focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody®...[read more]

2019-09-23

Affibody Relocates to the Karolinska Institute Campus in Solna...[read more]

2019-09-20

Affibody and GE Healthcare to Collaborate on Development of Affibody® PET...[read more]